Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7 <sup>th</sup> immunorad conference
Over the last decade, the annual Immunorad Conference, held under the joint auspicies of Gustave Roussy (Villejuif, France) and the Weill Cornell Medical College (New-York, USA) has aimed at exploring the latest advancements in the fields of tumor immunology and radiotherapy-immunotherapy combinations for the treatment of cancer. Gathering medical oncologists, radiation oncologists, physicians and researchers with esteemed expertise in these fields, the Immunorad Conference bridges the gap between preclinical outcomes and clinical opportunities. Thus, it paves a promising way toward optimizing radiotherapy-immunotherapy combinations and, from a broader perspective, improving therapeutic strategies for patients with cancer. Herein, we report on the topics developed by key-opinion leaders during the 7<sup>th</sup> Immunorad Conference held in Paris-Les Cordeliers (France) from September 27th to 29th 2023, and set the stage for the 8<sup>th</sup> edition of Immunorad which will be held at Weill Cornell Medical College (New-York, USA) in October 2024.
Authors
- Fabrice André (ORCID: https://orcid.org/0000-0001-5795-8357)
- Mikäel J. Pittet (ORCID: https://orcid.org/0000-0002-2060-4691)
- Etienne Meylan (ORCID: https://orcid.org/0000-0002-0899-2230)
- Claire Vanpouille‐Box (ORCID: https://orcid.org/0000-0001-7213-0670)
- Eric C Deutsch (ORCID: https://orcid.org/0000-0002-8223-3697)
- Matthias Gückenberger (ORCID: https://orcid.org/0000-0002-7146-9071)
- Sana D. Karam (ORCID: https://orcid.org/0000-0003-1676-5967)
- Claus Storgaard Sørensen (ORCID: https://orcid.org/0000-0001-6022-9710)
- Jean‐Pierre Pouget (ORCID: https://orcid.org/0000-0001-8551-2029)
- Pierre-Antoine Laurent (ORCID: https://orcid.org/0000-0002-1544-5390)
- Désirèe Deandreis (ORCID: https://orcid.org/0000-0002-3817-6648)
- Stefan B. Eichmüller (ORCID: https://orcid.org/0000-0002-3497-6904)
- Sandra Demaria (ORCID: https://orcid.org/0000-0003-4426-0499)
- Cristian Fernández-Palomo (ORCID: https://orcid.org/0000-0002-5095-262X)
- Ralph R. Weichselbaum (ORCID: https://orcid.org/0000-0002-5643-8939)
- Philippe Lambin
- Jordi Remón (ORCID: https://orcid.org/0000-0002-9462-875X)
- Fernanda Herrera (ORCID: https://orcid.org/0000-0001-7984-0472)
- Stéphane Depil (ORCID: https://orcid.org/0000-0001-6011-3945)
- Jérôme Galon (ORCID: https://orcid.org/0000-0001-9635-1339)
- Lorenzo Galluzzi (ORCID: https://orcid.org/0000-0003-2257-8500)
- Kevin Joseph Harrington (ORCID: https://orcid.org/0000-0002-6014-348X)
- Laurence Zitvogel (ORCID: https://orcid.org/0000-0003-1596-0998)
- James W. Welsh (ORCID: https://orcid.org/0000-0002-2255-8502)
- Carola Leuschner (ORCID: https://orcid.org/0000-0003-2219-2931)
- Floris Foijer (ORCID: https://orcid.org/0000-0003-0989-3127)
- Alexandre Bobard
- Alberto Mantovani (ORCID: https://orcid.org/0000-0001-6877-9848)
- Peter Huber (ORCID: https://orcid.org/0000-0003-3872-2343)
- Guido Kroemer
- Christos Sotiriou
- Silvia C. Formenti
- Antoine Italiano
- Michele Mondini (ORCID: https://orcid.org/0000-0001-5803-0083)
Institutions
- Université Claude Bernard Lyon 1 (FR)
- University of Geneva (CH)
- University of Bern (CH)
- University of Copenhagen (DK)
- Université Libre de Bruxelles (BE)
- Royal Marsden NHS Foundation Trust (GB)
- University Medical Center Groningen (NL)
- The University of Texas MD Anderson Cancer Center (US)
- Institute of Cancer Research (GB)
- Université de Bordeaux (FR)
- Inserm (FR)
- University of Groningen (NL)
- German Cancer Research Center (DE)
- Université de Montpellier (FR)
- Université Paris Cité (FR)
- Cornell University (US)
- Heidelberg University (DE)
- Université Paris-Saclay (FR)
- Maastricht University Medical Centre (NL)
- Institut Jules Bordet (BE)
- Institut Gustave Roussy (FR)
- University Hospital Heidelberg (DE)
- Lander Institute (IL)
- Maastricht University (NL)
- University of Illinois Chicago (US)
- Sorbonne Université (FR)
- University of Chicago (US)
- Sorbonne Paris Cité (FR)
- Centre de Recherche des Cordeliers (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- University Hospital of Zurich (CH)
- Heidelberger Institut für Radioonkologie (DE)
- Hôpital Européen Georges-Pompidou (FR)
- Centre Léon Bérard (FR)
- Hôpital Européen (FR)
- Ludwig Cancer Research (CH)
- Centre de Recherche en Cancérologie de Lyon (FR)
- Laboratoire d’immunologie intégrative du cancer (FR)
- Institut Bergonié (FR)
- Institut de Recherche en Cancérologie de Montpellier (FR)
- Clinique Claude-Bernard (FR)
- Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (FR)
- Institut National du Cancer (FR)
- Swiss Cancer Center Léman (CH)
- Center for Cancer Research (US)
- William Harvey Research Institute (GB)
- DKFZ-ZMBH Alliance (DE)
- IRCCS Humanitas Research Hospital (IT)
- Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (FR)
- Weill Cornell Medicine (US)
- Laboratoire Médiations (FR)
- NIHR Biomedical Research Centre at The Royal Marsden and the ICR
- University of Colorado Anschutz Medical Campus (US)
- Geneva College (US)
- University of Lausanne (CH)
Publication Details
- Journal
- OncoImmunology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1080/2162402x.2024.2432726
- Citations
- 6
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- European Commission